Article Text

other Versions

PDF
Insulin-like Growth Factor1 promoter polymorphisms and colorectal cancer: a functional genomics approach
  1. Hui-Lee Wong (wongh{at}mail.nih.gov)
  1. National Cancer Institute, United States
    1. Woon-Puay Koh (cofkwp{at}nus.edu.sg)
    1. National University of Singapore, Singapore
      1. Nicole M Probst-Hensch (nicole.probst{at}usz.ch)
      1. University of Zurich, Switzerland
        1. David Van Den Berg (dvandenb{at}usc.edu)
        1. University of Southern California, United States
          1. Mimi C Yu (mimiyu{at}umn.edu)
          1. University of Minnesota, United States
            1. Sue A Ingles (ingles{at}usc.edu)
            1. University of Southern California, United States

              Abstract

              Background Insulin-like Growth Factor (IGF)-1 has been proposed to mediate the obesity-related carcinogenic effects of 'western lifestyle'. While genetic factors explain at least half of inter-individual IGF1 variation, the IGF1 polymorphisms hypothesized to underlie the variation in cancer incidence rates remain ill-defined.

              Methods We used a comparative genomics approach to identify putative regulatory polymorphisms in the IGF1 promoter region within a rapidly westernizing population, the Singapore Chinese. Association of IGF1 genotype with colorectal cancer risk was assessed among 298 colorectal cancer cases and 1142 controls nested within the Singapore Chinese Health Study.

              Results We identified a common (minor allele frequency = 0.36) single nucleotide polymorphism (SNP), IGF1-2995 C/A, within a consensus domain for an octamer binding factor (Oct1/Oct2) transcription factor binding site. Possession of one or two copies of the minor allele (genotypes AA and CA) conferred an approximate 40 per cent decrease in risk in comparison to genotype CC (odds ratio: 0.59; 95 percent confidence interval: 0.45, 0.77). This association was stronger for colon than for rectal cancer (Ρheterogeneity< 0.001) and for those who were physically active vs. inactive (Ρinteraction=0.05). Models including other previously identified promoter polymorphisms did not provide a better prediction of colorectal cancer risk.

              Conclusions Our results support the hypotheses that IGF1 plays a role in colonic carcinogenesis and that genetically inherited variation in IGF1 expression influences risk of colorectal cancer.

              Statistics from Altmetric.com

              Request permissions

              If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

              Linked Articles

              • Digest
                Robin Spiller Magnus Simren